Coronary Artery Disease (CAD) and increasing technological advancements in cardiovascular diagnostics are key factors driving market revenue growth

NEW YORK CITY, NY, UNITED STATES, June 1, 2022 /EINPresswire.com/ -- The global heart attack diagnostics market size is expected to reach USD 224.65 Billion in 2030 and register a CAGR of 8.0% over the forecast period, according to the latest report by Reports and Data. Rising prevalence of CAD and increasing technological advancements in cardiovascular diagnostics are some key factors expected to drive market revenue growth over the forecast period. In addition, increasing number of obese population due to various factors such as excessive drinking, smoking, sedentary lifestyle, unhealthy eating habits, and no time for physical activities is contributing to rising cases of heart-related conditions globally, which is expected to support revenue growth of the global market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4132

Recent technological advancements in diagnostic imaging techniques is expected to drive market revenue growth of a significant extent. Availability of multiple imaging modalities is enabling healthcare professionals to accurately evaluate patients suspected of having coronary ischemia. Various imaging techniques such as stress echocardiography, stress electrocardiography, myocardial perfusion imaging, and magnetic resonance imaging among others is significantly improving treatment process by providing both anatomical and functional information of coronary stenosis. Computed Tomography (CT) angiography with perfusion, whole-heart magnetic resonance angiography, CT fractional flow reserve are evolving diagnostic pathway which has also been increasingly incorporated into routine clinical practice for diagnosing patients with CAD and this is expected to further drive market revenue growth over the forecast period.

Some Key Highlights From the Report:

In March 2021, Koninklijke Philips N.V. announced the launch of AI-enabled Precise Suite solution for the company’s incisive CT platform. The new technology provides smart workflows by utilizing AI-enabled image reconstruction technology, facilitating automated patient positioning, capturing motion-free cardiac image capture and enabling healthcare professionals to gain real-time interventional guidance, improve operational efficiency and provide quality care.

Electrocardiogram (ECG) segment is expected to account for largest revenue share during the forecast period attributable to increasing use of ECG diagnostic procedures in the diagnosis of cardiac conditions such as arrhythmia, congenital heart defects, coronary occlusion among others.

Hospitals segment is expected to lead in terms of revenue share over the forecast period owing to growing number of trans-catheter structural heart surgery and coronary artery bypass grafting procedures performed in hospitals to diagnose and treat coronary artery disease.

Non-invasive segment is expected to register robust revenue growth over the forecast period owing to increasing adoption of technologically advanced non-invasive diagnostic imaging modalities for providing real-time visualization of arterial wall and high-resolution image for accurate diagnosis of coronary artery disease.

North America is expected to account for largest revenue share over the forecast period attributable to rising number of elderly population, increasing demand for advanced diagnostic imaging techniques and growing investment in R&D activities for significantly improving identification and screening of heart diseases and contribute to improved diagnosis and facilitate targeted treatment.

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Heart Attack Diagnostics market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.

Leading companies operating in the market are:

Schiller AG, Siemens Healthineers AG, GE Healthcare Inc., F.Hoffman La-Roche Ltd., Midmark Corporation, Koninklijke Philips N.V., Hitachi Ltd., AstraZeneca PLC, Welch Allyn Inc., and Canon Medical Systems Corporation.

To know more about the report @ https://www.reportsanddata.com/report-detail/heart-attack-diagnostics-market

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Heart Attack Diagnostics Market Segmentation:

Diagnostics Procedure Outlook (Revenue, USD Billion; 2019-2030)

Invasive Procedure
Non-Invasive Procedure

Test Type Outlook (Revenue, USD Billion; 2019-2030)

Electrocardiogram (ECG or EKG)
Echocardiogram
Stress Test
Cardiac Catheterization
Cardiac Computerized Tomography (CT) Scan
Cardiac Magnetic Resonance Imaging(MRI)
Blood Test
Troponin
Brain Natriuretic Peptide(BNP)
Creatine Kinese MB (CK-MB)
Homocysteine
Other
Others

Regional Outlook:

North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
Italy
France
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
A.E.
South Africa
Rest of MEA

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/4132

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore Latest Trending Research Reports By Reports and Data's:

Targeted RNA Sequencing Market @ https://www.reportsanddata.com/report-detail/targeted-rna-sequencing-market

Pediatric Hearing Aids Market @ https://www.reportsanddata.com/report-detail/pediatric-hearing-aids-market

Amebocyte Lysate Market @ https://www.reportsanddata.com/report-detail/amebocyte-lysate-market

Capecitabine Market @ https://www.reportsanddata.com/report-detail/capecitabine-market

Digital Radiography Market @ https://www.reportsanddata.com/report-detail/digital-radiography-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Tushar Rajput
Reports and Data
+ + 12127101370
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.